top of page

CHO-K1/Human CTR-RAMP2 (AMY2) Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0042A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


AMY2 (CTR-RAMP2) is a subtype of the amylin receptor, a heterodimeric G protein-coupled receptor complex composed of the calcitonin receptor and receptor activity-modifying protein 2. It serves as a receptor not only for amylin but also for adrenomedullin. Compared to AMY1 and AMY3, its functional studies are still evolving, but it is known to be involved in regulating energy metabolism. Research indicates that the subunits of AMY2 tend to dissociate in the resting state, and binding of ligands like amylin promotes subunit association and activates downstream signaling pathways. Therefore, AMY2, along with AMY1 and AMY3, is considered part of the potential drug target network for treating type 2 diabetes and obesity.

 

Screeningbio’s CHO-K1/Human CTR-RAMP2 (AMY2) cell line overexpress both CT receptor and RAMP2 accessory protein (also named AMY2). The cell line is designed to detect increases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

CALCR & RAMP2

Accession Number

NM_001742 & NM_005854

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Human CTR-RAMP2 (AMY2) Agonist Assay. CHO-K1/Human CTR-RAMP2 (AMY2) cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Human CTR-RAMP2 (AMY2) Agonist Assay. CHO-K1/Human CTR-RAMP2 (AMY2) cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


AMY2 (CTR-RAMP2) is a subtype of the amylin receptor, a heterodimeric G protein-coupled receptor complex composed of the calcitonin receptor and receptor activity-modifying protein 2.


It serves as a receptor not only for amylin but also for adrenomedullin. Compared to AMY1 and AMY3, its functional studies are still evolving, but it is known to be involved in regulating energy metabolism. Research indicates that the subunits of AMY2 tend to dissociate in the resting state, and binding of ligands like amylin promotes subunit association and activates downstream signaling pathways.


Therefore, AMY2, along with AMY1 and AMY3, is considered part of the potential drug target network for treating type 2 diabetes and obesity.



 



Product Documentation



Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page